These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37232564)

  • 21. Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.
    Kadoyama K; Kuwahara A; Yamamori M; Brown JB; Sakaeda T; Okuno Y
    J Exp Clin Cancer Res; 2011 Oct; 30(1):93. PubMed ID: 21970649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.
    Tu AH; Chang EL
    Ophthalmology; 2005 Aug; 112(8):1469-71. PubMed ID: 15953639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cross-sectional optical coherence tomography study in patients on taxane-based therapy and a case report with the literature review.
    Kaya M; Atas F; Gulsum Guc Z; Oztop I; Durak I; Saatci AO
    Cutan Ocul Toxicol; 2020 Sep; 39(3):287-293. PubMed ID: 32619362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epiphora (excessive tearing) and other ocular manifestations related to weekly docetaxel: underestimated dose-limiting toxicity.
    Tsalic M; Gilboa M; Visel B; Miller B; Haim N
    Med Oncol; 2006; 23(1):57-61. PubMed ID: 16645230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical Trial.
    Nomura H; Aoki D; Michimae H; Mizuno M; Nakai H; Arai M; Sasagawa M; Ushijima K; Sugiyama T; Saito M; Tokunaga H; Matoda M; Nakanishi T; Watanabe Y; Takahashi F; Saito T; Yaegashi N;
    JAMA Oncol; 2019 Jun; 5(6):833-840. PubMed ID: 30896757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permanent hair loss associated with taxane chemotherapy use in breast cancer: A retrospective survey at two tertiary UK cancer centres.
    Chan J; Adderley H; Alameddine M; Armstrong A; Arundell D; Fox R; Harries M; Lim J; Salih Z; Tetlow C; Wong H; Thorp N
    Eur J Cancer Care (Engl); 2021 May; 30(3):e13395. PubMed ID: 33350015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmarketing safety of anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS).
    Omar NE; Fahmy Soliman AI; Eshra M; Saeed T; Hamad A; Abou-Ali A
    ESMO Open; 2021 Dec; 6(6):100315. PubMed ID: 34864500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.
    Qi WX; Shen Z; Lin F; Sun YJ; Min DL; Tang LN; He AN; Yao Y
    Curr Med Res Opin; 2013 Feb; 29(2):117-25. PubMed ID: 23216340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Docetaxel secretion in tears: association with lacrimal drainage obstruction.
    Esmaeli B; Ahmadi MA; Rivera E; Valero V; Hutto T; Jackson DM; Newman RA
    Arch Ophthalmol; 2002 Sep; 120(9):1180-2. PubMed ID: 12215091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
    Nyrop KA; Deal AM; Reeder-Hayes KE; Shachar SS; Reeve BB; Basch E; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
    Cancer; 2019 Sep; 125(17):2945-2954. PubMed ID: 31090930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do Steroids Matter? A Retrospective Review of Premedication for Taxane Chemotherapy and Hypersensitivity Reactions.
    Lansinger OM; Biedermann S; He Z; Colevas AD
    J Clin Oncol; 2021 Nov; 39(32):3583-3590. PubMed ID: 34357780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The postsaccal, idiopathic dacryostenosis--experimental and clinical aspects.
    Steinkogler FJ
    Doc Ophthalmol; 1986 Sep; 63(3):265-86. PubMed ID: 3780377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system.
    Wu Z; Zhou P; He N; Zhai S
    Front Cardiovasc Med; 2022; 9():966331. PubMed ID: 36352852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of excessive tearing in women with early breast cancer receiving adjuvant docetaxel-based chemotherapy.
    Chan A; Su C; de Boer RH; Gajdatsy A
    J Clin Oncol; 2013 Jun; 31(17):2123-7. PubMed ID: 23650421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel.
    Esmaeli B; Amin S; Valero V; Adinin R; Arbuckle R; Banay R; Do KA; Rivera E
    J Clin Oncol; 2006 Aug; 24(22):3619-22. PubMed ID: 16877729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erosive conjunctivitis and punctal stenosis secondary to docetaxel (taxotere).
    Skolnick CA; Doughman DJ
    Eye Contact Lens; 2003 Apr; 29(2):134-5. PubMed ID: 12695719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docetaxel-associated epiphora.
    Kintzel PE; Michaud LB; Lange MK
    Pharmacotherapy; 2006 Jun; 26(6):853-67. PubMed ID: 16716138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
    Chan YN; Jheng YW; Wang PJ; Chen CY; Lin MW; Wang YJ
    Clin J Oncol Nurs; 2019 Oct; 23(5):494-501. PubMed ID: 31538967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation and Management of Chemotherapy-Induced Epiphora, Punctal and Canalicular Stenosis, and Nasolacrimal Duct Obstruction.
    Mansur C; Pfeiffer ML; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2017; 33(1):9-12. PubMed ID: 27429222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Pentosan Polysulfate Sodium and Retinal Disorders.
    McGwin G; MacLennan P; Owsley C
    JAMA Ophthalmol; 2022 Jan; 140(1):37-42. PubMed ID: 34792558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.